Reviews Chloramphenicol Sodium Succinate


No reviews yet.

Chloramphenicol Sodium Succinate Drug Description
Chloramphenicol Sodium Succinate
(chloramphenicol sodium succinate) Injection

WARNING
Serious and fatal blood dyscrasias (aplastic anemia, hypoplastic anemia,
thrombocytopenia, and granulocytopenia) are known to occur after the administration
of chloramphenicol. In addition, there have been reports of aplastic anemia
attributed to chloramphenicol which later terminated in leukemia. Blood dyscrasias
have occurred after both short-term and prolonged therapy with this drug. Chloramphenicol
must not be used when less potentially dangerous agents will be effective, as
described in the INDICATIONS AND USAGE section. It must not be used in the
treatment of trivial infections or where it is not indicated, as in colds, influenza,
infections of the throat; or as a prophylactic agent to prevent bacterial infections.
Precautions: It is essential that adequate blood studies be made during
treatment with the drug. While blood studies may detect early peripheral blood
changes, such as leukopenia, reticulocytopenia, or granulocytopenia, before
they become irreversible, such studies cannot be relied on to detect bone marrow
depression prior to development of aplastic anemia. To facilitate appropriate
studies and observation during therapy, it is desirable that patients be hospitalized.
IMPORTANT CONSIDERATIONS IN PRESCRIBING INJECTABLE CHLORAMPHENICOL SODIUM
SUCCINATE. CHLORAMPHENICOL SODIUM SUCCINATE IS INTENDED FOR INTRAVENOUS USE
ONLY. IT HAS BEEN DEMONSTRATED TO BE INEFFECTIVE WHEN GIVEN INTRAMUSCULARLY.

Chloramphenicol sodium succinate must be hydrolyzed to its microbiologically
active form, and there is a lag in achieving adequate blood levels compared
with the base given intravenously.
Patients started on intravenous chloramphenicol sodium succinate should
be changed to the oral form of another appropriate antibiotic as soon as practicable.


DRUG DESCRIPTION
Chloramphenicol is an antibiotic that is clinically useful for, and should
be reserved for, serious infections caused by organisms susceptible to its
antimicrobial effects when less potentially hazardous therapeutic agents are
ineffective or contraindicated. Sensitivity testing is essential to determine
its indicated use, but may be performed concurrently with therapy initiated
on clinical impression that one of the indicated conditions exists (see INDICATIONS
AND USAGE section).
When reconstituted as directed, each vial contains a sterile solution equivalent
to 100 mg of chloramphenicol per mL (1g/10mL).
Each gram (10 mL of a 10% solution) of chloramphenicol sodium succinate contains
approximately 52 mg (2.25 mEq) of sodium.
The chemical name for chloramphenicol sodium succinate is D-threo-(-)-2, 2-Dichloro-N-[β-
hydroxy-α-(hydroxymethyl)-p-nitrophenethyl] acetamide α-(sodium
succinate).
The empirical and structural formulas are:







Last reviewed on RxList: 8/12/2008




Chloramphenicol Sodium Succinate Drug Description
Chloramphenicol Sodium Succinate
(chloramphenicol sodium succinate) Injection

WARNING
Serious and fatal blood dyscrasias (aplastic anemia, hypoplastic anemia,
thrombocytopenia, and granulocytopenia) are known to occur after the administration
of chloramphenicol. In addition, there have been reports of aplastic anemia
attributed to chloramphenicol which later terminated in leukemia. Blood dyscrasias
have occurred after both short-term and prolonged therapy with this drug. Chloramphenicol
must not be used when less potentially dangerous agents will be effective, as
described in the INDICATIONS AND USAGE section. It must not be used in the
treatment of trivial infections or where it is not indicated, as in colds, influenza,
infections of the throat; or as a prophylactic agent to prevent bacterial infections.
Precautions: It is essential that adequate blood studies be made during
treatment with the drug. While blood studies may detect early peripheral blood
changes, such as leukopenia, reticulocytopenia, or granulocytopenia, before
they become irreversible, such studies cannot be relied on to detect bone marrow
depression prior to development of aplastic anemia. To facilitate appropriate
studies and observation during therapy, it is desirable that patients be hospitalized.
IMPORTANT CONSIDERATIONS IN PRESCRIBING INJECTABLE CHLORAMPHENICOL SODIUM
SUCCINATE. CHLORAMPHENICOL SODIUM SUCCINATE IS INTENDED FOR INTRAVENOUS USE
ONLY. IT HAS BEEN DEMONSTRATED TO BE INEFFECTIVE WHEN GIVEN INTRAMUSCULARLY.

Chloramphenicol sodium succinate must be hydrolyzed to its microbiologically
active form, and there is a lag in achieving adequate blood levels compared
with the base given intravenously.
Patients started on intravenous chloramphenicol sodium succinate should
be changed to the oral form of another appropriate antibiotic as soon as practicable.


DRUG DESCRIPTION
Chloramphenicol is an antibiotic that is clinically useful for, and should
be reserved for, serious infections caused by organisms susceptible to its
antimicrobial effects when less potentially hazardous therapeutic agents are
ineffective or contraindicated. Sensitivity testing is essential to determine
its indicated use, but may be performed concurrently with therapy initiated
on clinical impression that one of the indicated conditions exists (see INDICATIONS
AND USAGE section).
When reconstituted as directed, each vial contains a sterile solution equivalent
to 100 mg of chloramphenicol per mL (1g/10mL).
Each gram (10 mL of a 10% solution) of chloramphenicol sodium succinate contains
approximately 52 mg (2.25 mEq) of sodium.
The chemical name for chloramphenicol sodium succinate is D-threo-(-)-2, 2-Dichloro-N-[β-
hydroxy-α-(hydroxymethyl)-p-nitrophenethyl] acetamide α-(sodium
succinate).
The empirical and structural formulas are:







Last reviewed on RxList: 8/12/2008




Chloramphenicol Sodium Succinate Drug Description
Chloramphenicol Sodium Succinate
(chloramphenicol sodium succinate) Injection

WARNING
Serious and fatal blood dyscrasias (aplastic anemia, hypoplastic anemia,
thrombocytopenia, and granulocytopenia) are known to occur after the administration
of chloramphenicol. In addition, there have been reports of aplastic anemia
attributed to chloramphenicol which later terminated in leukemia. Blood dyscrasias
have occurred after both short-term and prolonged therapy with this drug. Chloramphenicol
must not be used when less potentially dangerous agents will be effective, as
described in the INDICATIONS AND USAGE section. It must not be used in the
treatment of trivial infections or where it is not indicated, as in colds, influenza,
infections of the throat; or as a prophylactic agent to prevent bacterial infections.
Precautions: It is essential that adequate blood studies be made during
treatment with the drug. While blood studies may detect early peripheral blood
changes, such as leukopenia, reticulocytopenia, or granulocytopenia, before
they become irreversible, such studies cannot be relied on to detect bone marrow
depression prior to development of aplastic anemia. To facilitate appropriate
studies and observation during therapy, it is desirable that patients be hospitalized.
IMPORTANT CONSIDERATIONS IN PRESCRIBING INJECTABLE CHLORAMPHENICOL SODIUM
SUCCINATE. CHLORAMPHENICOL SODIUM SUCCINATE IS INTENDED FOR INTRAVENOUS USE
ONLY. IT HAS BEEN DEMONSTRATED TO BE INEFFECTIVE WHEN GIVEN INTRAMUSCULARLY.

Chloramphenicol sodium succinate must be hydrolyzed to its microbiologically
active form, and there is a lag in achieving adequate blood levels compared
with the base given intravenously.
Patients started on intravenous chloramphenicol sodium succinate should
be changed to the oral form of another appropriate antibiotic as soon as practicable.


DRUG DESCRIPTION
Chloramphenicol is an antibiotic that is clinically useful for, and should
be reserved for, serious infections caused by organisms susceptible to its
antimicrobial effects when less potentially hazardous therapeutic agents are
ineffective or contraindicated. Sensitivity testing is essential to determine
its indicated use, but may be performed concurrently with therapy initiated
on clinical impression that one of the indicated conditions exists (see INDICATIONS
AND USAGE section).
When reconstituted as directed, each vial contains a sterile solution equivalent
to 100 mg of chloramphenicol per mL (1g/10mL).
Each gram (10 mL of a 10% solution) of chloramphenicol sodium succinate contains
approximately 52 mg (2.25 mEq) of sodium.
The chemical name for chloramphenicol sodium succinate is D-threo-(-)-2, 2-Dichloro-N-[β-
hydroxy-α-(hydroxymethyl)-p-nitrophenethyl] acetamide α-(sodium
succinate).
The empirical and structural formulas are:







Last reviewed on RxList: 8/12/2008




Chloramphenicol Sodium Succinate Drug Description
Chloramphenicol Sodium Succinate
(chloramphenicol sodium succinate) Injection

WARNING
Serious and fatal blood dyscrasias (aplastic anemia, hypoplastic anemia,
thrombocytopenia, and granulocytopenia) are known to occur after the administration
of chloramphenicol. In addition, there have been reports of aplastic anemia
attributed to chloramphenicol which later terminated in leukemia. Blood dyscrasias
have occurred after both short-term and prolonged therapy with this drug. Chloramphenicol
must not be used when less potentially dangerous agents will be effective, as
described in the INDICATIONS AND USAGE section. It must not be used in the
treatment of trivial infections or where it is not indicated, as in colds, influenza,
infections of the throat; or as a prophylactic agent to prevent bacterial infections.
Precautions: It is essential that adequate blood studies be made during
treatment with the drug. While blood studies may detect early peripheral blood
changes, such as leukopenia, reticulocytopenia, or granulocytopenia, before
they become irreversible, such studies cannot be relied on to detect bone marrow
depression prior to development of aplastic anemia. To facilitate appropriate
studies and observation during therapy, it is desirable that patients be hospitalized.
IMPORTANT CONSIDERATIONS IN PRESCRIBING INJECTABLE CHLORAMPHENICOL SODIUM
SUCCINATE. CHLORAMPHENICOL SODIUM SUCCINATE IS INTENDED FOR INTRAVENOUS USE
ONLY. IT HAS BEEN DEMONSTRATED TO BE INEFFECTIVE WHEN GIVEN INTRAMUSCULARLY.

Chloramphenicol sodium succinate must be hydrolyzed to its microbiologically
active form, and there is a lag in achieving adequate blood levels compared
with the base given intravenously.
Patients started on intravenous chloramphenicol sodium succinate should
be changed to the oral form of another appropriate antibiotic as soon as practicable.


DRUG DESCRIPTION
Chloramphenicol is an antibiotic that is clinically useful for, and should
be reserved for, serious infections caused by organisms susceptible to its
antimicrobial effects when less potentially hazardous therapeutic agents are
ineffective or contraindicated. Sensitivity testing is essential to determine
its indicated use, but may be performed concurrently with therapy initiated
on clinical impression that one of the indicated conditions exists (see INDICATIONS
AND USAGE section).
When reconstituted as directed, each vial contains a sterile solution equivalent
to 100 mg of chloramphenicol per mL (1g/10mL).
Each gram (10 mL of a 10% solution) of chloramphenicol sodium succinate contains
approximately 52 mg (2.25 mEq) of sodium.
The chemical name for chloramphenicol sodium succinate is D-threo-(-)-2, 2-Dichloro-N-[β-
hydroxy-α-(hydroxymethyl)-p-nitrophenethyl] acetamide α-(sodium
succinate).
The empirical and structural formulas are:







Last reviewed on RxList: 8/12/2008




Chloramphenicol Sodium Succinate Drug Description
Chloramphenicol Sodium Succinate
(chloramphenicol sodium succinate) Injection

WARNING
Serious and fatal blood dyscrasias (aplastic anemia, hypoplastic anemia,
thrombocytopenia, and granulocytopenia) are known to occur after the administration
of chloramphenicol. In addition, there have been reports of aplastic anemia
attributed to chloramphenicol which later terminated in leukemia. Blood dyscrasias
have occurred after both short-term and prolonged therapy with this drug. Chloramphenicol
must not be used when less potentially dangerous agents will be effective, as
described in the INDICATIONS AND USAGE section. It must not be used in the
treatment of trivial infections or where it is not indicated, as in colds, influenza,
infections of the throat; or as a prophylactic agent to prevent bacterial infections.
Precautions: It is essential that adequate blood studies be made during
treatment with the drug. While blood studies may detect early peripheral blood
changes, such as leukopenia, reticulocytopenia, or granulocytopenia, before
they become irreversible, such studies cannot be relied on to detect bone marrow
depression prior to development of aplastic anemia. To facilitate appropriate
studies and observation during therapy, it is desirable that patients be hospitalized.
IMPORTANT CONSIDERATIONS IN PRESCRIBING INJECTABLE CHLORAMPHENICOL SODIUM
SUCCINATE. CHLORAMPHENICOL SODIUM SUCCINATE IS INTENDED FOR INTRAVENOUS USE
ONLY. IT HAS BEEN DEMONSTRATED TO BE INEFFECTIVE WHEN GIVEN INTRAMUSCULARLY.

Chloramphenicol sodium succinate must be hydrolyzed to its microbiologically
active form, and there is a lag in achieving adequate blood levels compared
with the base given intravenously.
Patients started on intravenous chloramphenicol sodium succinate should
be changed to the oral form of another appropriate antibiotic as soon as practicable.


DRUG DESCRIPTION
Chloramphenicol is an antibiotic that is clinically useful for, and should
be reserved for, serious infections caused by organisms susceptible to its
antimicrobial effects when less potentially hazardous therapeutic agents are
ineffective or contraindicated. Sensitivity testing is essential to determine
its indicated use, but may be performed concurrently with therapy initiated
on clinical impression that one of the indicated conditions exists (see INDICATIONS
AND USAGE section).
When reconstituted as directed, each vial contains a sterile solution equivalent
to 100 mg of chloramphenicol per mL (1g/10mL).
Each gram (10 mL of a 10% solution) of chloramphenicol sodium succinate contains
approximately 52 mg (2.25 mEq) of sodium.
The chemical name for chloramphenicol sodium succinate is D-threo-(-)-2, 2-Dichloro-N-[β-
hydroxy-α-(hydroxymethyl)-p-nitrophenethyl] acetamide α-(sodium
succinate).
The empirical and structural formulas are:







Last reviewed on RxList: 8/12/2008





Other reviews about Chloramphenicol Sodium Succinate on wordpress

Acyclovir,Zovirax
  by hijadoo
U.S. BRAND NAMES — Zovirax®PHARMACOLOGIC CATEGORY Antiviral AgentDOSING: ADULTS — Note: Obese patients should be dosed using ideal body weightGenital HSV: I.V.: Immunocompetent: Initial episode, severe: 5 […]


Glo- Folic Acid (Asam Folat)
  by obtrando
Background Folate and folic acid are forms of a water-soluble B vitamin. Folate occurs naturally in food and folic acid is the synthetic form of this vitamin. Folic acid […]


fyqtcuzjecos
  by zurzvfwboo
Mao safe emergency surgery technique Kamagra generic Excel left of character Licon and johsons plan Verizon inpulse plan Why did the bailout plan fail Bypass surgery after a heart attack Home phone plans for australia Powerpoint […]


The mans face has grown a litt
  by umortttizbgdu
Well, Ive just come from one and its the fifth night Ive slept so. He made a gallon of tea, fried some bacon, and brought out and toasted […]


Then, even more cautiously and slowly
  by wtsunrooalyso
Dors smiled without menaceand yet not exactly pleasantly, either. Carrying the largest stock of gold in the world, the world, in moments of danger, when crises of international […]


His voice was less harsh and
  by mvwbivabwsyvu
Smith laughed at them; but they insisted on loading a ship with the worthless stuff and sending it to London. It was beginning to rain again, and altogether […]


No one could sayno one ever did sa
  by jiqrzgmqbxc
For the Second Foundation, Seldons Plan, the Second Empire all impresses me not the least, nor touches any spring of compassion, sympathy, responsibility, nor any other source of […]


The morning was full of a new creatio
  by tbuxkdxlqr
The evening waned, and Geneva eventually retreated to her bedroom, leaving instructions to be awakened at once if the girl paid a visit. She did not believe she […]


But isnt it strange to
  by qqmijtqbwcf
At first he had wanted a witness; but that was when he thought the minikin would perish in the flames. believes that these four reputed species are all […]


I told you that this isn
  by amsejtzrsfc
THE ANSWER A Rose, in tatters on the garden path, Cried out to God and murmured gainst His Wrath, Because a sudden wind at twilights […]



Other reviews about Chloramphenicol Sodium Succinate on web:

Learn about the prescription medication Chloramphenicol Sodium Succinate (Chloramphenicol Sodium Succinate Injection), drug uses, dosage, side effects, drug interactions ... Chloramphenicol Sodium Succinate (Chloramphenicol Sodium Succinate ...


Chloramphenicol is a bacteriocidal antimicrobial. It is considered a prototypical broad-spectrum antibiotic, alongside the tetracyclines. Chloramphenicol is effective against a ... Chloramphenicol - Wikipedia, the free encyclopedia


Chloramphenicol Sodium Succinate Powder for Injection 100 mg/ml (as sodium succinate) when reconstituted 1 g vials; Chloromycetin ® Sodium Succinate (Parke ... Chloramphenicol


As soon as feasible an oral dosage form of another appropriate antibiotic should be substituted for intravenous chloramphenicol sodium succinate. DailyMed: About DailyMed


Chloramphenicol Pronunciation: (KLOR-am-FEN-ih-kahl) Class: Antibiotic, Anti-infective agent Trade Names: Chloromycetin Sodium Succinate - Powder for Injection 100 mg/mL (as base) when ... Complete Chloramphenicol information from Drugs.com


Chloromycetin Sodium Succinate (chloramphenicol) patient information. Detailed drug information for the consumer, includes dosage, Chloromycetin Sodium Succinate side effects and ... Chloromycetin Sodium Succinate consumer information from Drugs.com


Warning: This data is provided for information purpose only. You should not start or stop any medication without consulting your care giver. Use the Health Monitor application at ... CHLORAMPHENICOL SODIUM SUCCINATE ingredients, indications and use


UN/NA Number - The United Nations-North America number (also called UN number or DOT number). 4-digit number identifying an individual chemical or group of chemicals with similar ... CHLORAMPHENICOL SODIUM SUCCINATE | CAMEO Chemicals | NOAA


10/01/1987 - "We analyzed microsamples of plasma from an infant treated for meningitis with chloramphenicol sodium succinate intravenously. chloramphenicol succinate Summary Report | CureHunter


CATEGORIES: Infection, central nervous system Infection, rickettsia Infection, secondary to cystic fibrosis Meningitis Septicemia Typhoid fever FDA Approved 1959 Feb WHO Formulary Chloramphenicol Sodium Succinate





Featured Reviews

Reviews Bicillin L-A Injectable in Tubex

Bicillin L-A Injectable in Tubex Drug Description Bicillin® L-A (penicillin G benzathine) Injectable Suspension TUBEX® 1 mL and 2 mL for deep IM injection only WARNING: NOT FOR INTRAVENOUS USE. DO NOT INJECT INTRAVENOUSLY OR...
Read More  |  Review This
Reviews Celestone Soluspan

Celestone Soluspan Drug Description CELESTONE® SOLUSPAN® * (betamethasone sodium phosphate and betamethasone acetate) Injectable Suspension, USP 6 mg per mL *brand of rapid and repository injectable DRUG DESCRIPTION CELESTONE®...
Read More  |  Review This
Reviews Fortamet

Fortamet Drug Description FORTAMET® (metformin hydrochloride) Extended-Release Tablets DRUG DESCRIPTION What are the possible side effects of metformin (Fortamet, Glucophage, Glucophage XR, Glumetza, Riomet)? Get emergency...
Read More  |  Review This
Reviews Stimate

Stimate Drug Description Stimate® (desmopressin acetate) Nasal Spray, 1.5 mg/mL DRUG DESCRIPTION What are the possible side effects of desmopressin nasal (DDAVP Nasal, DDAVP Rhinal Tube, Stimate)? Get emergency medical help...
Read More  |  Review This
Reviews Persantine

Persantine IV Drug Description IV PERSANTINE® (dipyridamole USP) Prescribing Information DRUG DESCRIPTIONPersantine® (dipyridamole USP) for intravenous injection is a coronary vasodilator described as 2,6-Bis(diethanolamino)-4,8-dipip...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....